Suppr超能文献

地西泮治疗中重度酒精戒断反应

Diazepam in the Treatment of Moderate to Severe Alcohol Withdrawal.

作者信息

Weintraub Steven J

机构信息

Division of Hospital Medicine, Department of Medicine, Saint Louis Veterans Affairs Medical Center, John Cochran Division, 915 North Grand Avenue, Saint Louis, 63106, MO, USA.

Department of Internal Medicine, Washington University School of Medicine, Saint Louis, MO, USA.

出版信息

CNS Drugs. 2017 Feb;31(2):87-95. doi: 10.1007/s40263-016-0403-y.

Abstract

Benzodiazepines ameliorate or prevent the symptoms and complications of moderate to severe alcohol withdrawal, which can include autonomic hyperactivity, agitation, combativeness, hallucinations, seizures, delirium, and death. The benzodiazepines most commonly used for this purpose are lorazepam, chlordiazepoxide, oxazepam, and diazepam. It is widely asserted that no member of this group is superior to the others for treatment of alcohol withdrawal. However, of these, diazepam has the shortest time to peak effect, which facilitates both rapid control of symptoms and accurate titration to avoid over-sedation. Furthermore, diazepam and its active metabolite, desmethyldiazepam, have the longest elimination half-lives, so their levels decrease in a gradual, self-tapering manner, resulting in a smoother withdrawal, i.e., a lower incidence and severity of both breakthrough symptoms and rebound phenomena, including a possibly decreased seizure risk. Importantly, the fear of increased risk of over-sedation with diazepam compared with other benzodiazepines is based on a misunderstanding of its pharmacokinetics and is unfounded. Similarly, the notion that diazepam should be avoided in patients with liver disease and elderly patients to avoid prolonged over-sedation is based on no more than conjecture. In fact, there is clinical evidence that diazepam is safe for the treatment of alcohol withdrawal in these patients when administered using a simple symptom-based approach. There is one instance in which diazepam should not be used: when intramuscular administration is the only option, the lipophilicity of diazepam can result in slow absorption-either lorazepam or, when rapid control of symptoms is required, midazolam should be used. The comparative pharmacokinetics of the benzodiazepines used in the treatment of alcohol withdrawal together with a comprehensive review of the literature on their use strongly suggest that diazepam should be the preferred benzodiazepine for the treatment of patients experiencing moderate to severe alcohol withdrawal under most circumstances.

摘要

苯二氮䓬类药物可改善或预防中重度酒精戒断的症状及并发症,这些症状和并发症可能包括自主神经功能亢进、激越、好斗、幻觉、癫痫发作、谵妄及死亡。最常用于此目的的苯二氮䓬类药物有劳拉西泮、氯氮䓬、奥沙西泮和地西泮。人们普遍认为,该类药物中没有哪一种在治疗酒精戒断方面优于其他药物。然而,其中地西泮达到峰值效应的时间最短,这有利于快速控制症状以及精确滴定以避免过度镇静。此外,地西泮及其活性代谢产物去甲地西泮的消除半衰期最长,因此它们的血药浓度以逐渐自行递减的方式下降,从而实现更平稳的戒断过程,即突破性症状和戒断反应的发生率及严重程度更低,包括癫痫发作风险可能降低。重要的是,与其他苯二氮䓬类药物相比,担心地西泮会增加过度镇静风险是基于对其药代动力学的误解,是毫无根据的。同样,认为肝病患者和老年患者应避免使用地西泮以防止长期过度镇静的观点也仅仅是推测。事实上,有临床证据表明,当采用基于简单症状的方法给药时,地西泮用于这些患者的酒精戒断治疗是安全的。有一种情况不应使用地西泮:当只能选择肌内注射时,地西泮的亲脂性会导致吸收缓慢,此时应使用劳拉西泮,或者在需要快速控制症状时使用咪达唑仑。用于治疗酒精戒断的苯二氮䓬类药物的比较药代动力学以及对其使用文献的全面综述有力地表明,在大多数情况下,地西泮应是治疗中重度酒精戒断患者的首选苯二氮䓬类药物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验